As the use of AI spreads through every industry and becomes more of a part of our lives every day, researchers are also ...
Servier today announced longer-term data from the Phase 3 INDIGO trial evaluating VORANIGO® (vorasidenib) versus placebo in patients with Grade 2 mutant isocitrate dehydrogenase 1 or 2 (mIDH1/2) ...
Servier today announced that VORANIGO® (vorasidenib) has been awarded The Galien Foundation's 2025 Prix Galien USA ...
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced the launch of its ...
Fake honey is a global concern. New research offers quick tests to spot cheaper materials mixed into pure honey. Scientists ...
Enzyme mechanisms are the chemical transformations, and the steps within them, generated by enzymatic action on substrates. The mechanism of enzyme catalysis is similar in principle to other types of ...
In two replicate Phase 3 studies, upadacitinib (RINVOQ ® ) achieved the co-primary endpoints of 50% reduction in Total Vitiligo Area Scoring Index (T-VASI 50) from baseline and 75% reduction in Facial ...
Objective: To describe the joint manifestations associated with clonal haematopoiesis and to compare patients with and ...
Objective To investigate the association between peripheral disease activity and pre-eclampsia, gestational hypertension, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback